Dendreon

Dendreon posied to get decent mark from German regulator, says RBC Capital
The Fly on the Wall
Wed, 01/11/12 - 10:56 am
Dendreon
Germany
Dendreon: The Surge Continues
Seeking Alpha
Tue, 01/10/12 - 09:51 am
Dendreon
Provenge
Biotech Investors Buoyed By Signs Of Speedier Drug Launches
Seeking Alpha
Mon, 01/9/12 - 10:40 am
drug launches
Dendreon
Incyte
Human Genome Sciences
Regeneron
Seattle Genetics
Vertex
Dendreon Rally Justified, But Outstanding Issues May Limit Upside
Seeking Alpha
Mon, 01/9/12 - 10:29 am
Dendreon
Provenge
Dendreon, JAZZ and Regeneron Among Best Stock Price Performers
Yahoo/Wall St. Cheat Sheet
Sat, 01/7/12 - 01:26 pm
Dendreon
Jazz
Regeneron
Dendreon: Provenge Sales Surprise On Upside, Bodes Well For The Stock
Seeking Alpha
Sat, 01/7/12 - 01:20 pm
Dendreon
Provenge
Dendreon Surges After Fourth-Quarter Product Revenue Triples
Bloomberg Businessweek
Thu, 01/5/12 - 12:45 pm
Dendreon
earnings
Provenge
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
3 Biotechs Hopefully To Get Rich Or Die Trying
Seeking Alpha
Wed, 01/4/12 - 09:28 am
Advanced Cell Technologies
Aeterna Zentaris
BioSante
Dendreon
Keryx
Health Care's Worst Stocks 2011: Dendreon
Motley Fool
Mon, 12/26/11 - 08:52 am
Dendreon
Dendreon demonstrates tougher commercialization hurdles for developers
Fierce Biotech
Fri, 12/23/11 - 09:02 am
Dendreon
Provenge
5 Potential Big Movers In Pharma For 2012
Seeking Alpha
Thu, 12/22/11 - 06:45 am
CytoSorbents
Dendreon
Lpath
SIGA technologies
Prolor
Dendreon: Where Do Things Stand On Provenge Reimbursement?
Seeking Alpha
Wed, 12/21/11 - 12:56 pm
Provenge
prostate cancer
Dendreon
Dendreon 2011: Supply Constrained to Missed Guidance
Motley Fool
Fri, 12/16/11 - 11:31 am
Dendreon
guidance
Provenge
prostate cancer
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thu, 12/15/11 - 12:08 pm
cancer
Antigenics
Amgen
Bristol-Myers Squibb
Celgene
Dendreon
Generex
Merck KGaA
GSK
Idera Pharmaceuticals
NewLink Genetics
Novartis
Roche
Oncothyreon
Transgene
Vical
20 Biotech Stocks That Hedge Funds Are Selling
Seeking Alpha
Sun, 12/11/11 - 02:40 pm
Nabi
Pacific Biosciences
Dendreon
Momenta
Enzon
Acorda Therapeutics
ShangPharma
Charles River Laboratories
Sangamo BioSciences
BioSpecifics Technologies
Jazz Pharmaceuticals
Amgen
Sinovac Biotech
ViroPharma
Vanda
Insmed
Transcept
Cadence Pharmaceuticals
PDL Biopharma
Chelsea Therapeutics
The Worst Biotech CEO of 2011 Is ...
TheStreet.com
Fri, 12/9/11 - 10:57 am
biotech
Mitchell Gold
Dendreon
Dendreon to sell royalty in Merck hep C drug
Reuters
Tue, 12/6/11 - 04:30 pm
Merck
Dendreon
hepatitis C
Victrelis
Health Care's 5 Worst November Flops
Motley Fool
Thu, 12/1/11 - 11:42 am
Vertex
Seattle Genetics
Human Genome Sciences
Mako Surgical
Dendreon
7 Black Friday Biotech Bargains
Motley Fool
Sat, 11/26/11 - 10:50 am
Dendreon
Human Genome Sciences
GSK
Avanir
Exelixis
MannKind
Amarin
Vertex Pharmaceuticals

Pages